{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:21:53Z","timestamp":1791292913246,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2017,11]]},"abstract":"\n Background<\/jats:title>\n \n Cardiovascular disease is emerging as a major cause of morbidity and mortality among patients with\n HIV<\/jats:styled-content>\n . We compared use of national guideline\u2010recommended cardiovascular care during office visits among\n HIV<\/jats:styled-content>\n \u2010infected versus\n HIV<\/jats:styled-content>\n \u2010uninfected adults.\n <\/jats:p>\n <\/jats:sec>\n \n Methods and Results<\/jats:title>\n \n We analyzed data from a nationally representative sample of\n HIV<\/jats:styled-content>\n \u2010infected and\n HIV<\/jats:styled-content>\n \u2010uninfected patients aged 40 to 79 years in the National Ambulatory Medical Care Survey\/National Hospital Ambulatory Medical Care Survey, 2006 to 2013. The outcome was provision of guideline\u2010recommended cardiovascular care. Logistic regressions with propensity score weighting adjusted for clinical and demographic factors. We identified 1631 visits by\n HIV<\/jats:styled-content>\n \u2010infected patients and 226\u00a0862 visits by\n HIV<\/jats:styled-content>\n \u2010uninfected patients with cardiovascular risk factors, representing \u22482.2\u00a0million and 602\u00a0million visits per year in the United States, respectively. The proportion of visits by\n HIV<\/jats:styled-content>\n \u2010infected versus\n HIV<\/jats:styled-content>\n \u2010uninfected adults with aspirin\/antiplatelet therapy when patients met guideline\u2010recommended criteria for primary prevention or had cardiovascular disease was 5.1% versus 13.8% (\n P<\/jats:italic>\n =0.03); the proportion of visits with statin therapy when patients had diabetes mellitus, cardiovascular disease, or dyslipidemia was 23.6% versus 35.8% (\n P<\/jats:italic>\n <0.01). There were no differences in antihypertensive medication therapy (53.4% versus 58.6%), diet\/exercise counseling (14.9% versus 16.9%), or smoking cessation advice\/pharmacotherapy (18.8% versus 22.4%) between\n HIV<\/jats:styled-content>\n \u2010infected versus\n HIV<\/jats:styled-content>\n \u2010uninfected patients, respectively.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n \n Physicians generally underused guideline\u2010recommended cardiovascular care and were less likely to prescribe aspirin and statins to\n HIV<\/jats:styled-content>\n \u2010infected patients at increased risk\u2014findings that may partially explain higher rates of adverse cardiovascular events among patients with\n HIV<\/jats:styled-content>\n . US policymakers and professional societies should focus on improving the quality of cardiovascular care that\n HIV<\/jats:styled-content>\n \u2010infected patients receive.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1161\/jaha.117.007107","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T01:10:47Z","timestamp":1510708247000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":80,"title":["Disparities in the Quality of Cardiovascular Care Between HIV\u2010Infected Versus HIV\u2010Uninfected Adults in the United States: A Cross\u2010Sectional Study"],"prefix":"10.1161","volume":"6","author":[{"given":"Joseph A.","family":"Ladapo","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam K.","family":"Richards","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra M.","family":"DeWitt","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina T.","family":"Harawa","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Shoptaw","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Mafi","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, CA"},{"name":"RAND Corporation, Santa Monica, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2015.10.030"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/652283"},{"key":"e_1_3_5_4_2","unstructured":"Centers for Disease Control and Prevention . HIV Surveillance Report 2015. 2016."},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001560"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.02.024"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0954"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-016-0321-0"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.4494"},{"key":"e_1_3_5_10_2","unstructured":"National Center for Health Statistics (U.S.) . Ambulatory Health Care Data: NAMCS and NHAMCS description. 2013; June 4 2013: Published on ftp site April 26 2012."},{"key":"e_1_3_5_11_2","unstructured":"National Center for Health Statistics (U.S.) . 2009 NAMCS Public\u2010use Data File Documentation. 2009."},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0296"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.2081"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-6-200903170-00009"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0b013e318277d6a0"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.106.25.3143"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.19.2560"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-8-200904210-00009"},{"key":"e_1_3_5_19_2","first-page":"1931","article-title":"Behavioral counseling in primary care to promote physical activity: recommendations and rationale","volume":"66","author":"U. S. Preventive Services Task Force","year":"2002","unstructured":"U. S. Preventive Services Task Force . Behavioral counseling in primary care to promote physical activity: recommendations and rationale. Am Fam Physician. 2002;66:1931\u20131936.","journal-title":"Am Fam Physician"},{"key":"e_1_3_5_20_2","first-page":"2573","article-title":"Behavioral counseling in primary care to promote a healthy diet: recommendations and rationale","volume":"67","author":"U. S. Preventive Services Task Force","year":"2003","unstructured":"U. S. Preventive Services Task Force . Behavioral counseling in primary care to promote a healthy diet: recommendations and rationale. Am Fam Physician. 2003;67:2573\u20132576.","journal-title":"Am Fam Physician"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003\u20104819\u2010153\u201011\u2010201012070\u201000007"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/003335491513000619"},{"key":"e_1_3_5_23_2","article-title":"Continuity of care for chronic conditions: threats, opportunities, and policy","volume":"2016","author":"Ladapo JA","year":"2014","unstructured":"Ladapo JA, Chokshi DA. Continuity of care for chronic conditions: threats, opportunities, and policy. Health Affairs Blog. 2014;2016. Available at http:\/\/www.healthaffairs.org\/do\/10.1377\/hblog20141118.042672\/full\/. Accessed November 8, 2017.","journal-title":"Health Affairs Blog"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq111"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1515\/jci-2014-0039"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.12090"},{"key":"e_1_3_5_27_2","unstructured":"National Center for Health Statistics (U.S.) . Ambulatory Health Care Data: NAMCS and NHAMCS Reliability of Estimates. 2013. Published on ftp site April 26 2012."},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-014-3107-3"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-008-0805-8"},{"key":"e_1_3_5_30_2","unstructured":"U.S. National Institutes of Health . Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV\u2010Infected Adults (REPRIEVE). 2016;2017."},{"key":"e_1_3_5_31_2","first-page":"146","article-title":"HIV\u2010related cardiovascular disease, statins, and the REPRIEVE trial","volume":"23","author":"Gilbert JM","year":"2015","unstructured":"Gilbert JM, Fitch KV, Grinspoon SK. HIV\u2010related cardiovascular disease, statins, and the REPRIEVE trial. Top Antivir Med. 2015;23:146\u2013149.","journal-title":"Top Antivir Med"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis752"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000360"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.6822"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.735340"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.117.007107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:40:11Z","timestamp":1715596811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.117.007107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.1161\/JAHA.117.007107"],"URL":"https:\/\/doi.org\/10.1161\/jaha.117.007107","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"2017-07-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-10-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-11-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e007107"}}